The Wellcome Trust has awarded Miratul Muqit an Enhancement Award to support a Postdoctoral Fellowship to investigate molecular mechanisms of Parkinson's disease.
The 3-year fellowship will build on ground breaking studies from the Muqit lab on the regulation and downstream function of the PINK1 kinase that is mutated in Parkinson's. This led to the discovery that PINK1 targets ubiquitin to generate a novel chemical messenger molecule phospho-ubiquitin.
The successful candidate will deploy state-of-the-art technologies to investigate how PINK1 activation and phospho-ubiquitin are critical for protecting against Parkinson's disease.
For information on how to apply please click here.
The 3-year fellowship will build on ground breaking studies from the Muqit lab on the regulation and downstream function of the PINK1 kinase that is mutated in Parkinson's. This led to the discovery that PINK1 targets ubiquitin to generate a novel chemical messenger molecule phospho-ubiquitin.
The successful candidate will deploy state-of-the-art technologies to investigate how PINK1 activation and phospho-ubiquitin are critical for protecting against Parkinson's disease.
For information on how to apply please click here.